The chemical class known as TRAV17 Activators encompasses a diverse range of compounds that can influence the activation of T cells through various signaling pathways and cellular processes. These activators work by modulating critical steps within the signaling cascades that ultimately lead to T cell activation, a process in which the T-cell receptors (TCRs), potentially including those that incorporate the TRAV17 gene segment, play a critical role. The activation of T cells is a complex event that requires the precise coordination of multiple signals and intracellular messengers. The chemicals classified as TRAV17 Activators can affect these signals by altering the activity of enzymes, changing concentrations of secondary messengers, or modifying the expression and function of key signaling proteins.
In detail, TRAV17 Activators can initiate their effect by targeting protein kinases that are essential in the transduction of signals from the TCR to the cell's nucleus, leading to the expression of genes necessary for T cell activation. These activators can also increase intracellular calcium levels, which serve as a pivotal secondary messenger in T cells, further propagating the activation signal. Inhibition of specific phosphatases or kinases by these chemicals can result in the modulation of transcription factors and other proteins that are crucial for the full activation of T cells. Additionally, these activators can influence the trafficking and processing of proteins that are involved in T cell responses, thus altering the cellular landscape and affecting TCR-mediated activation. It is through these multifaceted mechanisms that the class of chemicals known as TRAV17 Activators can exert their influence on the complex process of T cell activation, without directly interacting with the TRAV17 gene segment itself.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
Activates protein kinase C (PKC), which is part of the TCR signaling pathway. PKC activation leads to downstream events that could possibly activate T cells expressing TRAV17-containing TCRs. | ||||||
Ionomycin, free acid | 56092-81-0 | sc-263405 sc-263405A | 1 mg 5 mg | $94.00 $259.00 | 2 | |
Increases intracellular calcium concentration, a secondary messenger in TCR-mediated signal transduction, which could possibly activate T cells with TRAV17-inclusive TCRs. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $62.00 $90.00 $299.00 $475.00 $1015.00 $2099.00 | 69 | |
Inhibits calcineurin, which normally dephosphorylates NFAT, a transcription factor important in T cell activation. Its inhibition results in altered T cell responses and could possibly activate T cells in a TRAV17-related context. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Stimulates adenylate cyclase, increasing cAMP levels, which could possibly activate T cells by modulating PKA activity and downstream signaling pathways linked to TRAV17. | ||||||
Prostratin | 60857-08-1 | sc-203422 sc-203422A | 1 mg 5 mg | $138.00 $530.00 | 24 | |
Activates PKC like PMA and could possibly activate T cells by enhancing signaling through the TRAV17-inclusive TCR. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
Inhibits the SERCA, leading to increased intracellular calcium levels and could possibly activate T cells by affecting calcium-dependent signaling pathways in a TRAV17-related manner. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Inhibits mTOR, a central regulator of T cell metabolism and function, which could possibly activate or inhibit T cells in a TRAV17-dependent manner, depending on the context. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $30.00 $52.00 $122.00 $367.00 | 25 | |
Disrupts protein transport, which could possibly activate T cells by affecting the processing and presentation of signaling molecules through TRAV17-inclusive TCRs. | ||||||
Zoledronic acid, anhydrous | 118072-93-8 | sc-364663 sc-364663A | 25 mg 100 mg | $90.00 $251.00 | 5 | |
Inhibits farnesyl pyrophosphate synthase, which could possibly activate T cells by affecting prenylation of small GTPases involved in TCR signaling including TRAV17. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
Inhibits MEK in the MAPK/ERK pathway, a key signaling pathway downstream of TCR activation, which could possibly activate T cells with TRAV17-inclusive TCRs. | ||||||